Pfizer Announces Test Results of Coranavirus Drug

Pfizer, which has made a name for itself for a long time with the coronavirus vaccine it has developed with BioNTech, has announced that the antiviral pill it continues to produce against the coronavirus. 89 percent It has been announced recently that it is effective in the ratio. Application made to the US Food and Drug Administration (FDA) for the use of the drug approval Waiting.

Today, according to the final test results of the drug by Pfizer, it is also very successful in the hospitalization rate. and at the same time It also protects from the Omicron variant. announced.

Once approved, 180 thousand doses will be produced this year.

The antiviral pill produced by Pfizer against coronavirus last month, 1200 people 89 percent of hospitalization and death rates, according to their experiments on protection was declared. Today, the final test results of the drug have been announced. No one taking Pfizer’s medication, according to tests involving more than 1,000 participants. he didn’t die. According to a second test result, among citizens using the drug 70% reduction in hospitalization rate seen.

Regarding the data released today, Mikael Dolsten from Pfizer said, “A great result. We’re talking about saving a huge number of lives and preventing hospitalization. If the drug is activated quickly after infection We can also seriously prevent the spread of” made a statement. He also stated that the drug worked as well in the Omicron variant as it did in other variants, according to recent laboratory tests.

The coronavirus drug previously developed by the pharmaceutical company Merck Molnupavir It was started to be used with the approval of England. Collaborating with BioNtech to produce a coronavirus vaccine, Pfizer is waiting for the result of the application to get approval for use with the antiviral pill it has developed against coronavirus. With the approval of use Paxlovid drug to be sold under the name It is planned to produce 180 thousand doses this year and at least 80 million doses next year. Paxlovid, a drug developed by Pfizer, will be released as the second coronavirus drug if approved.